Intravitreal (IVI) anti-vascular endothelial growth factor (anti-VEGF) injections are used to treat retinal diseases [1] including wet age-related macular degeneration (wAMD), choroidal neovascularization, polypoidal choroidal vasculopathy (PCV) as well as macular edema secondary to other causes [2]. Here, VEGFA is linked to Abnormal retinal morphology.